GB9106048D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB9106048D0
GB9106048D0 GB919106048A GB9106048A GB9106048D0 GB 9106048 D0 GB9106048 D0 GB 9106048D0 GB 919106048 A GB919106048 A GB 919106048A GB 9106048 A GB9106048 A GB 9106048A GB 9106048 D0 GB9106048 D0 GB 9106048D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919106048A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GB919106048A priority Critical patent/GB9106048D0/en
Publication of GB9106048D0 publication Critical patent/GB9106048D0/en
Priority claimed from CA 2092827 external-priority patent/CA2092827A1/en
Priority claimed from KR1019930700978A external-priority patent/KR100194079B1/en
Priority claimed from NO933342A external-priority patent/NO933342D0/en
Application status is Pending legal-status Critical

Links

GB919106048A 1991-03-21 1991-03-21 Vaccines Pending GB9106048D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines
CA 2092827 CA2092827A1 (en) 1990-09-28 1991-09-21 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
AU85109/91A AU654970B2 (en) 1990-09-28 1991-09-21 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
KR1019930700978A KR100194079B1 (en) 1990-09-28 1991-09-21 A pharmaceutical for preventing or treating infection Hiv compositions and methods for their preparation
EP19910916067 EP0550485A1 (en) 1990-09-28 1991-09-21 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT
PCT/EP1991/001810 WO1992006113A2 (en) 1990-09-28 1991-09-21 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT
JP51492691A JPH06501151A (en) 1990-09-28 1991-09-21
EP94202409A EP0644201A1 (en) 1990-09-28 1991-09-21 Derivatives of gpl60 and vaccines based on gpl60 or a derivative thereof, containing an adjuvant
MX9101275A MX9101275A (en) 1990-09-28 1991-09-26 Protein gp160 of human immunodeficiency virus and vaccine compositions containing the same or its derivative
IE338591A IE913385A1 (en) 1990-09-28 1991-09-26 Novel compounds
NZ23994891A NZ239948A (en) 1990-09-28 1991-09-26 Hiv gp160 modified at positions 502 and 510, vaccines and recombinant methods for producing modified gp160
PT9906391A PT99063B (en) 1990-09-28 1991-09-26 Process for the production of a glycoprotein and vaccines that contains it
PCT/EP1991/002047 WO1992016556A1 (en) 1991-03-21 1991-10-25 Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
HU9302642A HU9302642D0 (en) 1991-03-21 1991-10-25 Gp 160-derivatives and vaccine containing them or gp-160 itself
SK82593A SK82593A3 (en) 1991-03-21 1991-10-25 Derivatives opf 160 and vaccines based on gp 160 or a derivative thereof, containing an adjuvant
HU264293A HUT67011A (en) 1991-03-21 1991-10-25 Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
BR9107294A BR9107294A (en) 1991-03-21 1991-10-25 Derived from GP160 and GP160 based vaccines or a derivative thereof, containing an adjuvant
IL9989991A IL99899D0 (en) 1991-03-21 1991-10-30 Vaccines
YU174491A YU174491A (en) 1991-03-21 1991-11-01 vaccines
AP9100332A AP368A (en) 1991-03-21 1991-11-04 Derivatives of gp160 and vaccine based on gp160 or a derivative thereof, containing an adjuvant.
CN 91111514 CN1064891A (en) 1991-03-21 1991-11-09 Vaccines
MA22665A MA22381A1 (en) 1991-03-21 1991-12-30 Vaccine Production Method
NO933342A NO933342D0 (en) 1991-03-21 1993-09-20 Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
FI934133A FI934133A0 (en) 1991-03-21 1993-09-21 Derivater of gp160 och som vacciner baserar sig pao gp160 eller och dess derivative of a innhaoller tillsatsmedel
CZ931957A CZ195793A3 (en) 1991-03-21 1993-10-25 Derivatives gp160 and vaccine based on gp160 or on a derivative of said substance, containing an auxiliary component

Publications (1)

Publication Number Publication Date
GB9106048D0 true GB9106048D0 (en) 1991-05-08

Family

ID=10691984

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919106048A Pending GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines

Country Status (12)

Country Link
CN (1) CN1064891A (en)
AP (1) AP368A (en)
BR (1) BR9107294A (en)
CZ (1) CZ195793A3 (en)
FI (1) FI934133A0 (en)
GB (1) GB9106048D0 (en)
HU (2) HU9302642D0 (en)
IL (1) IL99899D0 (en)
MA (1) MA22381A1 (en)
SK (1) SK82593A3 (en)
WO (1) WO1992016556A1 (en)
YU (1) YU174491A (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
CN1087176C (en) * 1993-03-23 2002-07-10 史密斯克莱·比奇曼生物公司 Vaccine compositions containing 3-O deacylated monophosphoryl lipid A
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CN1304580C (en) * 2004-07-09 2007-03-14 楼伟 Surface glucoprotein gp160 of recombination expression human acquired immunity defact virus 1
WO2006011060A2 (en) 2004-07-23 2006-02-02 Chiron Srl Polypeptides for oligomeric assembly of antigens
AU2005287505A1 (en) 2004-09-22 2006-03-30 Biosynexus Incorporated Staphylococcal immunogenic compositions
EP2447719B1 (en) 2007-02-26 2016-08-24 Oxford BioTherapeutics Ltd Proteins
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
CA2750581A1 (en) 2009-01-21 2010-07-29 Oxford Biotherapeutics Ltd. Pta089 protein
EP2496605A1 (en) 2009-11-02 2012-09-12 Oxford Biotherapeutics Ltd. Ror1 as therapeutic and diagnostic target
DK2726094T3 (en) 2011-06-28 2017-02-06 Oxford Biotherapeutics Ltd Therapeutic and diagnostic targets
GB201213364D0 (en) 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
BR112018073690A2 (en) 2016-05-16 2019-02-26 Infectious Disease Res Institute TLR agonist containing formulation and methods of use
CA3023672A1 (en) 2016-05-16 2017-11-23 Infectious Disease Research Institute Pegylated liposomes and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89567D0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein

Also Published As

Publication number Publication date
WO1992016556A1 (en) 1992-10-01
IL99899D0 (en) 1992-08-18
AP368A (en) 1994-10-28
AP9100332A0 (en) 1992-01-31
BR9107294A (en) 1994-06-14
FI934133D0 (en)
SK82593A3 (en) 1994-01-12
FI934133A (en) 1993-09-21
MA22381A1 (en) 1992-07-01
HUT67011A (en) 1995-01-30
HU9302642D0 (en) 1994-01-28
YU174491A (en) 1994-06-10
CN1064891A (en) 1992-09-30
CZ195793A3 (en) 1994-05-18
FI934133A0 (en) 1993-09-21

Similar Documents

Publication Publication Date Title
US5143923B1 (en) Benzoisothiazole-and benzisoxazole-3-carboxamides
DE69216251D1 (en) Substituierte aryl- und heteroaryl-phenyloxazolidinone
KR100218594B1 (en) Bis-benzofuran-2-ones
DE69224906D1 (en) Thermotropes flüssig-kristallines segment-blockcopolymer
DE69222933D1 (en) Cholangiographiekatheter
DE69228822D1 (en) Intubationsvorrichtung
DE69129193D1 (en) Triterpenderivat
DE69228192D1 (en) Wellpappe-palette
DE69213441D1 (en) Analsphinkterprothese
GB2257579B (en) Pin-header
DE69222628D1 (en) Wärmeisolationsmaterial
CY2593B2 (en) Adjuvants for vaccines
GR3029882T3 (en) Adjuvants
NZ243454A (en) (indolylmethylene)-2-oxindoles
HK1011348A1 (en) Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
DE69228486D1 (en) Thrombosefilter
ZA9202420B (en) Grf-analogs ii
HU9201031D0 (en) Rapamycine-xilyle-ethers
HUT63774A (en) Dust-inhaler
ZA9203210B (en) Pyrrolindinones
SG48971A1 (en) Enzyme-orthokeratology
GR3021894T3 (en) Pallet-container
HK1000319A1 (en) 9-Amino-7-substituted-6-demethyl-6-deoxytetracyclines
IL101290D0 (en) Vaccine formulations
HU9302983D0 (en) Quinoline-derivatives